Exploring Common CDISC ADaM Dataset Conformance Findings
What you need to know when validating your CDISC ADAM datasets During the regulatory review…
CertaraSeptember 3, 2020
Clinical trials of disease stages in COVID 19: complicated and often misinterpreted
As of July 28, 2020, 1840 clinical trials were registered globally, with 1001 clinical trials…
CertaraAugust 22, 2020
Accelerating Clinical Evaluation of Repurposed Combination Therapies for COVID-19
As the global COVID-19 pandemic continues, unabated and clinical trials demonstrate limited effective pharmaceutical interventions,…
CertaraAugust 22, 2020
Application of PK/PD Modeling and Simulation in Drug Discovery and Development in China
By Yuancheng Chen, Research Associate of Phase 1 Unit, Huashan Hospital, Fudan University, and visiting…
CertaraAugust 7, 2020
Quantitative Systems Pharmacology approaches for immuno‐oncology: adding virtual patients to the development paradigm
Drug development in oncology commonly exploits the tools of molecular biology to gain therapeutic benefit…
CertaraJuly 26, 2020
Model‐Informed Drug Repurposing: Viral Kinetic Modeling to Prioritize Rational Drug Combinations for COVID‐19
We hypothesized that viral kinetic modeling could be helpful to prioritize rational drug combinations for…
CertaraJuly 26, 2020
Salvaging CNS Clinical Trials Halted Due to COVID‐19
The coronavirus disease 2019 (COVID‐19) pandemic has halted many ongoing central nervous system (CNS) clinical…
CertaraJuly 15, 2020
